Published in Antimicrob Agents Chemother on May 20, 2013
Plasmid-mediated quinolone resistance. Microbiol Spectr (2014) 1.13
Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci (2015) 1.00
The role of 2,4-dihydroxyquinoline (DHQ) in Pseudomonas aeruginosa pathogenicity. PeerJ (2016) 0.77
Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli. Front Microbiol (2017) 0.75
Unique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance Genes. mSphere (2017) 0.75
Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci U S A (1994) 11.44
Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A (2002) 7.76
A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1995) 7.66
Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1999) 5.58
Purification and structural identification of an autoinducer for the luminescence system of Vibrio harveyi. J Biol Chem (1989) 5.55
Multiple N-acyl-L-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1995) 4.77
Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis (2006) 3.66
Quorum sensing, communication and cross-kingdom signalling in the bacterial world. Microbiology (2007) 2.58
Cell-to-cell signalling in Escherichia coli and Salmonella enterica. Mol Microbiol (2004) 2.15
Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob Agents Chemother (2007) 1.78
Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev (2011) 1.75
Development of the quinolones. J Antimicrob Chemother (2003) 1.49
Natural products as starting points for future anti-malarial therapies: going back to our roots? Malar J (2011) 1.22
SOS regulation of qnrB expression. Antimicrob Agents Chemother (2008) 1.16
PqsD is responsible for the synthesis of 2,4-dihydroxyquinoline, an extracellular metabolite produced by Pseudomonas aeruginosa. J Biol Chem (2008) 1.11
Prevalence and characteristics of β-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China. J Antimicrob Chemother (2012) 1.07
The quinine connection. J Antimicrob Chemother (1992) 1.05
Quorum sensing signal molecules (acylated homoserine lactones) in gram-negative fish pathogenic bacteria. Dis Aquat Organ (2005) 1.04
Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. Int J Tryptophan Res (2012) 0.95
Phylogenetic analysis of chromosomally determined qnr and related proteins. Antimicrob Agents Chemother (2013) 0.90
Detection of quorum sensing signal molecules in the family Vibrionaceae. J Appl Microbiol (2011) 0.86
Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system. Antimicrob Agents Chemother (2011) 0.83
History of science: quinine steps back in time. Nature (2008) 0.81
Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A (2002) 7.76
Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother (2002) 7.73
The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis (2006) 7.20
Updated functional classification of beta-lactamases. Antimicrob Agents Chemother (2009) 7.16
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med (2005) 7.15
Hospital-acquired infections due to gram-negative bacteria. N Engl J Med (2010) 6.61
Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother (2003) 6.26
qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother (2006) 5.50
Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother (2006) 4.96
Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev (2009) 4.43
Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother (2005) 4.03
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med (2008) 3.88
Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis (2013) 3.78
Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis (2006) 3.66
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56
Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother (2004) 3.54
Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother (2003) 3.13
Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother (2005) 2.90
Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother (2008) 2.70
blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother (2002) 2.47
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother (2009) 2.32
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis (2003) 2.06
Case records of the Massachusetts General Hospital. Case 3-2015. A 60-year-old woman with abdominal pain, dyspnea, and diplopia. N Engl J Med (2015) 1.97
Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol (2003) 1.81
oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother (2009) 1.77
Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis (2013) 1.57
Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis (2004) 1.56
NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol (2008) 1.47
Recurrent meningitis of unknown aetiology. Lancet (2004) 1.43
A recA-LexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus. J Biol Chem (2003) 1.41
NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.37
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother (2002) 1.34
Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis (2007) 1.32
Activity of and resistance to moxifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother (2003) 1.30
Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant. Biochemistry (2008) 1.27
Detection of postoperative surgical-site infections: comparison of health plan-based surveillance with hospital-based programs. Infect Control Hosp Epidemiol (2003) 1.27
Citrobacter spp. as a source of qnrB Alleles. Antimicrob Agents Chemother (2011) 1.26
The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus. J Bacteriol (2007) 1.26
vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother (2010) 1.25
Transferable quinolone resistance in Vibrio cholerae. Antimicrob Agents Chemother (2009) 1.22
Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals. Clin Infect Dis (2002) 1.17
Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob Agents Chemother (2009) 1.17
SOS regulation of qnrB expression. Antimicrob Agents Chemother (2008) 1.16
Enhanced surgical site infection surveillance following hysterectomy, vascular, and colorectal surgery. Infect Control Hosp Epidemiol (2012) 1.14
Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J Biol Chem (2011) 1.13
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 28-2015. A 32-Year-Old Man with Fever, Headache, and Myalgias after Traveling from Liberia. N Engl J Med (2015) 1.13
Quinolone resistance due to reduced target enzyme expression. J Bacteriol (2003) 1.13
Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997-2007. Clin Infect Dis (2012) 1.12
Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005. Clin Infect Dis (2009) 1.10
NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J Bacteriol (2002) 1.10
Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol (2011) 1.09
Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother (2004) 1.08
Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus. J Bacteriol (2008) 1.07
Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC Infect Dis (2014) 1.04
Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin. Antimicrob Agents Chemother (2005) 1.03
Antibiotic dosing before primary hip and knee replacement as a pay-for-performance measure. J Bone Joint Surg Am (2007) 1.02
Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus. J Bacteriol (2010) 1.02
Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother (2003) 0.98
Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob Agents Chemother (2011) 0.97
Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: the patient access managers' perspective. Infect Control Hosp Epidemiol (2012) 0.94
Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivo. J Bacteriol (2012) 0.94
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia. Clin Infect Dis (2014) 0.92
DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases. Antimicrob Agents Chemother (2005) 0.91
TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother (2002) 0.91
Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations. Antimicrob Agents Chemother (2002) 0.90
Phylogenetic analysis of chromosomally determined qnr and related proteins. Antimicrob Agents Chemother (2013) 0.90
Beta-lactamase nomenclature. J Clin Microbiol (2005) 0.90
Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin. J Infect Dis (2013) 0.89
Mutational analysis of quinolone resistance protein QnrB1. Antimicrob Agents Chemother (2013) 0.89
Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones. Antimicrob Agents Chemother (2006) 0.88
National survey of infection preventionists: policies for discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol (2012) 0.88
An improved expression plasmid for affinity purification of Staphylococcus aureus gyrase A subunit. Protein Expr Purif (2005) 0.88
Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea. J Antimicrob Chemother (2013) 0.87
Reduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA. J Bacteriol (2012) 0.87
Implication of the NorB efflux pump in the adaptation of Staphylococcus aureus to growth at acid pH and in resistance to moxifloxacin. Antimicrob Agents Chemother (2011) 0.85
Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system. Antimicrob Agents Chemother (2011) 0.83
Cold shock induces qnrA expression in Shewanella algae. Antimicrob Agents Chemother (2010) 0.82
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus. J Med Chem (2005) 0.82
Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother (2013) 0.79
Fungus-infected fluid collections in thorax or abdomen: effectiveness of percutaneous catheter drainage. Radiology (2005) 0.79
Regulation of expression of abcA and its response to environmental conditions. J Bacteriol (2014) 0.79